|Minimum Order Quantity||10 Piece|
|Product Type||Finished Product|
|Medicine Type||Ayurvedic, Allopathic|
|Dosage Form||Injection, Tablet, Capsule|
|Minimum Order Quantity||30 Piece|
|Minimum Order Quantity||100 Piece|
|Packaging Size||30 ml|
|CEFPODOXIME PROXETIL 50MG/5ML||30ML|
To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefpodoxime proxetil and other antibacterial drugs, cefpodoxime proxetil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. Cefpodoxime proxetil is a prodrug; its active metabolite is cefpodoxime. All doses of cefpodoxime proxetil in this insert are expressed in terms of the active cefpodoxime moiety. The drug is supplied as flavored granules for oral suspension. Cefpodoxime proxetil is a prodrug that is absorbed from the gastrointestinal tract and de-esterified to its active metabolite, cefpodoxime. Following oral administration of 100 mg of cefpodoxime proxetil to fasting subjects, approximately 50% of the administered cefpodoxime dose was absorbed systemically.
Mechanism of Action:
Cefpodoxime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefpodoxime has activity in the presence of some beta-lactamases, both penicillinases and cephalosporinases, of Gram-negative and Gram-positive bacteria for ex. Escherichia coliKlebsiella pneumonia ,Proteus mirabilis ,Haemophilus influenzae (including beta-lactamase producing isolates) Moraxella catarrhalis , Neisseria gonorrhoeae (including penicillinase-producing isolates) , Streptococcus agalactiae, Streptococcus spp. (Groups C, F, G)
Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes.
Community-acquired pneumonia caused by S. pneumoniae or H. Influenzae (including beta-lactamase-producing strains).
Acute, uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains).
Acute, uncomplicated ano-rectal infections in women due to Neisseria gonorrhoeae (including penicillinase-producing strains).
Pharma Franchise Opportunity
PCD Pharma franchise
Pharmaceutical Third Party Manufacturing
Pharmaceutical contract Manufacturing Services
Rated by 20 Users